According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 164,234,000. At the end of 2023 the company had 164,234,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.16 B | 1.39% |
2022 | 0.16 B | 0.7% |
2021 | 0.16 B | 1.01% |
2020 | 0.15 B | 3.09% |
2019 | 0.15 B | 17.37% |
2018 | 0.13 B | 6.05% |
2017 | 0.12 B | 2.41% |
2016 | 0.12 B | 19.76% |
2015 | 0.10 B | 1.36% |
2014 | 99.85 M | 11.56% |
2013 | 89.5 M | 47.65% |
2012 | 60.61 M | 14.81% |
2011 | 52.8 M | 37.56% |
2010 | 38.38 M | 2.68% |
2009 | 37.38 M | 0.66% |
2008 | 37.13 M | 0.52% |
2007 | 36.94 M | 24.26% |
2006 | 29.73 M | 27.37% |
2005 | 23.34 M | 40.38% |
2004 | 16.62 M | 46.32% |
2003 | 11.36 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,408,200,000 | 1,366.32% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 3,338.39% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 478.06% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,023,000,000 | 1,131.78% | ๐บ๐ธ USA |
Vanda Pharmaceuticals VNDA | 57,532,309 | -64.97% | ๐บ๐ธ USA |
Adamas Pharmaceuticals
ADMS | 28,158,200 | -82.85% | ๐บ๐ธ USA |